MicroRNA-214 Mediates Isoproterenol-induced Proliferation and Collagen Synthesis in Cardiac Fibroblasts

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Sun, Min ^a   Yu, Haiyi ^a   Zhang, Youyi ^a   Li, Zijian ^a   Gao, Wei ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; COLLAGEN; ISOPRENALINE; MEMBRANE PROTEIN; MICRORNA; MIRN214 MICRORNA,RAT; MITOCHONDRIAL PROTEIN; MITOFUSIN 2 PROTEIN, RAT; MITOGEN ACTIVATED PROTEIN KINASE;

3' UNTRANSLATED REGION; ANIMAL; BINDING SITE; BIOSYNTHESIS; CARDIAC MUSCLE; CELL PROLIFERATION; CONSERVED SEQUENCE; DOWN REGULATION; DRUG EFFECTS; FIBROBLAST; FIBROSIS; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; UPREGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL PROLIFERATION; COLLAGEN; CONSERVED SEQUENCE; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; FIBROSIS; GENE KNOCKDOWN TECHNIQUES; ISOPROTERENOL; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICRORNAS; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE DATA; MYOCARDIUM; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; TRANSFECTION; UP-REGULATION;

EID: 84951310254     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18351     Document Type: Article

References (42)

1. Kong, P., Christia, P. & Frangogiannis, N. G. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 71, 549-574 (2014).
2. Tao, H. et al. Epigenetic regulation of cardiac fibrosis. Cell Signal 25, 1932-1938 (2013).
3. Florea, V. G. & Cohn, J. N. The Autonomic Nervous System and Heart Failure. Circ Res 114, 1815-1826 (2014).
4. Liu, N. et al. HIP-55/DBNL-dependent regulation of adrenergic receptor mediates the ERK1/2 proliferative pathway. Mol Biosyst 10, 1932-1939 (2014).
5. Lu, H. et al. Danshensu inhibits beta-adrenergic receptors-mediated cardiac fibrosis by ROS/p38 MAPK axis. Biol Pharm Bull 37, 961-967 (2014).
6. Chen, C. et al. beta-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCdelta/p38 MAPK signalling in neonatal mouse cardiac fibroblasts. Br J Pharmacol 166, 676-688 (2012).
7. Kim, J., Eckhart, A. D., Eguchi, S. & Koch, W. J. Beta-adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases. J Biol Chem 277, 32116-32123 (2002).
8. Bauersachs, J. Regulation of myocardial fibrosis by MicroRNAs. J Cardiovasc Pharmacol 56, 454-459 (2010).
9. Da, C. M. P. et al. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 118, 1567-1576 (2008).
10. Chen, S. et al. Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med 18, 415-421 (2014).
11. Castoldi, G. et al. MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J Cell Physiol 227, 850-856 (2012).
12. Limana, F. et al. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PLoS One 6, e19845 (2011).
13. Roy, S. et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 82, 21-29 (2009).
14. Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984 (2008).
15. Zhang, Y. et al. miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-beta/Smad3 signaling. Mol Ther 22, 974-985 (2014).
16. Zhu, J. N. et al. Smad3 inactivation and MiR-29b upregulation mediate the effect of carvedilol on attenuating the acute myocardium infarction-induced myocardial fibrosis in rat. PLoS One 8, e75557 (2013).
17. Hou, Y. et al. beta-adrenoceptor regulates miRNA expression in rat heart. Med Sci Monit 18, R309-R314 (2012).
18. van Rooij, E. et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103, 18255-18260 (2006).
19. Denby, L. et al. MicroRNA-214 Antagonism Protects against Renal Fibrosis. J Am Soc Nephrol 25, 65-80 (2014).
20. Chen, K. H. et al. Role of mitofusin 2 (Mfn2) in controlling cellular proliferation. Faseb J 28, 382-394 (2014).
21. Ikeda, S. et al. Altered microRNA expression in human heart disease. Physiol Genomics 31, 367-373 (2007).
22. Duan, Q. L. et al. MicroRNA-214 Is Upregulated in Heart Failure Patients and Suppresses XBP1-Mediated Endothelial Cells Angiogenesis. J Cell Physiol 230, 1964-1973 (2015).
23. 2. Biochem Biophys Res Commun 436, 578-584 (2013).
24. Aurora, A. B. et al. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+ ) overload and cell death. J Clin Invest 122, 1222-1232 (2012).
25. 2O2-induced injury. J Cell Biochem 115, 93-101 (2014).
26. Yang, H. et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68, 425-433 (2008).
27. Zhang, X. J. et al. Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J Hematol Oncol 3, 46 (2010).
28. Yang, Z. et al. MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. Iubmb Life 61, 1075-1082 (2009).
29. Wang, X. et al. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of beta-catenin. Biochem Biophys Res Commun 428, 525-531 (2012).
30. Misiewicz-Krzeminska, I. et al. Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication. Haematologica 98, 640-648 (2013).
31. Yang, T. et al. Cardiac hypertrophy and dysfunction induced by overexpression of miR-214 in vivo. J Surg Res 192, 317-325 (2014).
32. Coll, M. et al. Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells. Sci Rep. 5, 11549 (2015).
33. Zhang, M., Wang, X., Li, W. & Cui, Y. miR-107 and miR-25 simultaneously target LATS2 and regulate proliferation and invasion of gastric adenocarcinoma (GAC) cells. Biochem Biophys Res Commun. 460, 806-812 (2015).
34. Chen, K. C. et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J. 25, 1718-1728 (2011).
35. Ishteiwy, R. A., Ward, T. M., Dykxhoorn, D. M. & Burnstein, K. L. The microRNA-23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells. PLoS One. 7, e52106 (2012).
36. Guo, R., Gu, J., Zhang, Z., Wang, Y. & Gu, C. MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer. IUBMB Life. 67, 42-53 (2015).
37. Yu, S. et al. miR-326 Targets Antiapoptotic Bcl-xL and Mediates Apoptosis in Human Platelets. PLoS One. 10, e0122784 (2015).
38. de Brito, O. M. & Scorrano, L. Mitofusin-2 regulates mitochondrial and endoplasmic reticulum morphology and tethering: the role of Ras. Mitochondrion 9, 222-226 (2009).
39. Tang, W. X., Wu, W. H., Zeng, X. X., Bo, H. & Huang, S. M. Early protective effect of mitofusion 2 overexpression in STZ-induced diabetic rat kidney. Endocrine 41, 236-247 (2012).
40. Pages, G. et al. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 90, 8319-8323 (1993).
41. Hayashida, T., Decaestecker, M. & Schnaper, H. W. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. Faseb J 17, 1576-1578 (2003).
42. Simpson, P. & Savion, S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ Res 50, 101-116 (1982).